{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T16:04:52Z","timestamp":1793030692985,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.jchf.2017.04.012","type":"journal-article","created":{"date-parts":[[2017,7,14]],"date-time":"2017-07-14T15:24:20Z","timestamp":1500045860000},"page":"543-551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":494,"title":["The Transition From Hypertension to\u00a0Heart\u00a0Failure"],"prefix":"10.1016","volume":"5","author":[{"given":"Franz H.","family":"Messerli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano F.","family":"Rimoldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sripal","family":"Bangalore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchf.2017.04.012_bib1","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1001\/jama.1996.03530440037034","article-title":"The progression from hypertension to congestive heart failure","volume":"275","author":"Levy","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2017.04.012_bib2","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1161\/01.CIR.0000039105.49749.6F","article-title":"Lifetime risk for developing congestive heart failure: the Framingham Heart Study","volume":"106","author":"Lloyd-Jones","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2017.04.012_bib3","first-page":"911","article-title":"Hypertension, obesity, diabetes, and heart failure-free survival: the Cardiovascular Disease Lifetime Risk Pooling Project","volume":"4","author":"Ahmad","year":"2016","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jchf.2017.04.012_bib4","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1001\/jama.2011.1821","article-title":"Association between chlorthalidone treatment of systolic hypertension and long-term survival","volume":"306","author":"Kostis","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2017.04.012_bib5","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0140-6736(82)92234-6","article-title":"Cardiovascular effects of obesity and hypertension","volume":"1","author":"Messerli","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.jchf.2017.04.012_bib6","first-page":"445","article-title":"Older adults, \u201cmalignant\u201d left ventricular hypertrophy, and associated cardiac-specific biomarker phenotypes to identify the differential risk of new-onset reduced versus preserved ejection fraction heart failure: CHS (Cardiovascular Health Study)","volume":"3","author":"Seliger","year":"2015","journal-title":"J\u00a0Am Coll Cardiol HF"},{"issue":"Suppl J","key":"10.1016\/j.jchf.2017.04.012_bib7","first-page":"95","article-title":"Classification of hypertensive cardiomyopathy","volume":"14","author":"Iriarte","year":"1993","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2017.04.012_bib8","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A\u00a0novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2017.04.012_bib9","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1161\/CIRCULATIONAHA.114.009625","article-title":"Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction","volume":"131","author":"Mohammed","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2017.04.012_bib10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1056\/NEJM200101043440103","article-title":"The pathogenesis of acute pulmonary edema associated with hypertension","volume":"344","author":"Gandhi","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2017.04.012_bib11","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1136\/pgmj.54.633.440","article-title":"Diagnosis and natural history of congested (dilated) cardiomyopathies","volume":"54","author":"Oakley","year":"1978","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.jchf.2017.04.012_bib12","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.amjcard.2010.10.014","article-title":"Trials on the effect of cardiac resynchronization on arterial blood pressure in patients with heart failure","volume":"107","author":"Ather","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jchf.2017.04.012_bib13","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1253\/circj.CJ-08-0553","article-title":"Change in blood pressure just after initiation of cardiac resynchronization therapy predicts long-term clinical outcome in patients with advanced heart failure","volume":"73","author":"Tanaka","year":"2009","journal-title":"Circ J"},{"key":"10.1016\/j.jchf.2017.04.012_bib14","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ejheart.2007.06.001","article-title":"Ejection fraction and blood pressure are important and interactive predictors of 4-week mortality in severe acute heart failure","volume":"9","author":"Adamopoulos","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2017.04.012_bib15","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1056\/NEJMoa051530","article-title":"Outcome of heart failure with preserved ejection fraction in a population-based study","volume":"355","author":"Bhatia","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2017.04.012_bib16","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1001\/jama.293.5.572","article-title":"Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis","volume":"293","author":"Fonarow","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2017.04.012_bib17","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1001\/jama.296.18.2217","article-title":"Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure","volume":"296","author":"Gheorghiade","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2017.04.012_bib18","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ahj.2005.03.009","article-title":"The association between blood pressure and mortality in patients with heart failure","volume":"151","author":"Lee","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.jchf.2017.04.012_bib19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1067\/mhj.2002.119608","article-title":"Clinical features and outcomes of elderly outpatients with heart failure followed up in hospital cardiology units: data from a large nationwide cardiology database (IN-CHF Registry)","volume":"143","author":"Pulignano","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.jchf.2017.04.012_bib20","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1056\/NEJM199908193410806","article-title":"Hormones and hemodynamics in heart failure","volume":"341","author":"Schrier","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2017.04.012_bib21","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.jacc.2003.11.037","article-title":"Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study","volume":"43","author":"Rouleau","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2017.04.012_bib22","doi-asserted-by":"crossref","first-page":"784","DOI":"10.7326\/0003-4819-150-11-200906020-00006","article-title":"Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure","volume":"150","author":"McAlister","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jchf.2017.04.012_bib23","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","article-title":"Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study","volume":"376","author":"Swedberg","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jchf.2017.04.012_bib24","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1161\/HYPERTENSIONAHA.116.07250","article-title":"Selective heart rate reduction with ivabradine increases central blood pressure in stable coronary artery disease","volume":"67","author":"Rimoldi","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.jchf.2017.04.012_bib25","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.jacc.2016.03.610","article-title":"When an increase in central systolic pressure overrides the benefits of heart rate lowering","volume":"68","author":"Messerli","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2017.04.012_bib26","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1161\/CIRCULATIONAHA.109.886473","article-title":"Cardiorenal syndrome: new perspectives","volume":"121","author":"Bock","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2017.04.012_bib27","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jacc.2012.01.077","article-title":"Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure","volume":"60","author":"Ronco","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2017.04.012_bib28","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1093\/eurheartj\/ehw222","article-title":"A\u00a0propitious time for initiating clinical trials in patients with heart failure with reduced ejection fraction and an estimated glomerular filtration rate\u00a0<30 mL\/min with an mineralocorticoid receptor antagonist and a K+ binder: 'the forbidden fruit'","volume":"37","author":"Epstein","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2017.04.012_bib29","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0140-6736(88)92668-2","article-title":"Recurrent pulmonary oedema in hypertension due to bilateral renal artery stenosis: treatment by angioplasty or surgical revascularisation","volume":"2","author":"Pickering","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.jchf.2017.04.012_bib30","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1093\/eurheartj\/ehr056","article-title":"Flash pulmonary oedema and bilateral renal artery stenosis: the Pickering syndrome","volume":"32","author":"Messerli","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2017.04.012_bib31","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.pcad.2009.10.002","article-title":"Flash pulmonary edema","volume":"52","author":"Rimoldi","year":"2009","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.jchf.2017.04.012_bib32","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.jacc.2005.10.009","volume":"47","author":"Hirsch","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2017.04.012_bib33","doi-asserted-by":"crossref","first-page":"i1855","DOI":"10.1136\/bmj.i1855","article-title":"Effect of age and sex on efficacy and tolerability of beta blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis","volume":"353","author":"Kotecha","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jchf.2017.04.012_bib34","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.jacc.2008.05.057","article-title":"Beta-blockers for primary prevention of heart failure in patients with hypertension insights from a meta-analysis","volume":"52","author":"Bangalore","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2017.04.012_bib35","first-page":"CD003654","article-title":"Calcium channel blockers versus other classes of drugs for hypertension","volume":"8","author":"Chen","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jchf.2017.04.012_bib36","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/HJH.0000000000000848","article-title":"Effects of blood pressure-lowering treatment: 6. Prevention of heart failure and new-onset heart failure\u2013meta-analyses of randomized trials","volume":"34","author":"Thomopoulos","year":"2016","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jchf.2017.04.012_bib37","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.mayocp.2015.10.019","article-title":"Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in patients without heart failure? Insights from 254,301 patients from randomized trials","volume":"91","author":"Bangalore","year":"2016","journal-title":"Mayo Clinic Proc"},{"key":"10.1016\/j.jchf.2017.04.012_bib38","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1161\/CIRCULATIONAHA.116.025950","article-title":"Angiotensin receptor blockers reduce cardiovascular events, including the risk of myocardial infarction","volume":"135","author":"Messerli","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2017.04.012_bib39","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1093\/eurheartj\/ehv142","article-title":"Role of neprilysin inhibitor combinations in hypertension: insights from hypertension and heart failure trials","volume":"36","author":"Bavishi","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2017.04.012_bib40","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2017.04.012_bib41","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1001\/jama.1991.03460240051027","article-title":"Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group","volume":"265","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2017.04.012_bib42","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMoa0801369","article-title":"Treatment of hypertension in patients 80 years of age or older","volume":"358","author":"Beckett","year":"2008","journal-title":"N\u00a0Engl J Med"}],"updated-by":[{"DOI":"10.1016\/j.jchf.2017.10.007","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000}}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177917303177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177917303177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T02:55:24Z","timestamp":1535597724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177917303177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S2213177917303177"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2017.04.012","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Transition From Hypertension to\u00a0Heart\u00a0Failure","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2017.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}